Glipizide 10 MG Oral Tablet

Known as: GLIPIZIDE 10MG TAB [VA Product], GLIPIZIDE 10MG TAB, GLIPIZIDE 10MG TAB,UD [VA Product] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2004
02420002004

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
AIMS This study evaluated the effects on glycemic control of the addition of 2.5 mg glipizide GITS to metformin in patients with… (More)
Is this relevant?
2004
2004
OBJECTIVE Evaluation of effects of glipizide gastrointestinal therapeutic system (GITS) administered once daily (AM or PM) and… (More)
Is this relevant?
2002
2002
OBJECTIVE Epidemiological studies have implicated increased plasminogen-activated inhibitor 1 (PAI-1) as a marker or predictor of… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2002
2002
This study was designed to compare the pharmacokinetic and short-term pharmacodynamic profile of extended-release glipizide GITS… (More)
Is this relevant?
2002
2002
The entrapment and retention of plasma low-density lipoproteins (LDL) by arterial proteoglycans (PG) is a process central to… (More)
Is this relevant?
2002
2002
OBJECTIVE This study compared persistence on and adherence to therapy with glipizide gastrointestinal therapeutic system (GITS… (More)
Is this relevant?
Review
2000
Review
2000
UNLABELLED Glipizide is a second generation sulphonylurea agent that is available in a Gastrointestinal Therapeutic System (GITS… (More)
Is this relevant?